Key stats
About Invesco Nasdaq Biotechnology ETF
Home page
Inception date
Jun 11, 2021
Structure
Open-Ended Fund
Replication method
Physical
Dividend treatment
Distributes
Distribution tax treatment
Qualified dividends
Income tax type
Capital Gains
Max ST capital gains rate
39.60%
Max LT capital gains rate
20.00%
Primary advisor
Invesco Capital Management LLC
Distributor
Invesco Distributors, Inc.
IBBQ provides exposure to US biotech and pharma companies that are exclusively listed on the NASDAQ Stock Market. The index includes companies classified under the biotechnology or pharmaceuticals sub sector of the Industry Classification Benchmark. Companies from any capitalization may be included, but since weighting is based on market cap, it produces a basket that heavily favors large-caps and concentrates exposure in the top names. Individual holdings are subject to capping requirements, 8% on the five largest constituents and 4% for the remaining. IBBQ may miss opportunities in companies traded on the NYSE, which several of the other similar funds are eligible to hold. The index is rebalanced quarterly and reconstituted annually in December.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks99.94%
Health Technology96.63%
Commercial Services1.51%
Technology Services1.14%
Health Services0.64%
Process Industries0.03%
Bonds, Cash & Other0.06%
Mutual fund0.04%
Cash0.02%
Stock breakdown by region
North America82.11%
Europe17.40%
Asia0.41%
Oceania0.08%
Latin America0.00%
Africa0.00%
Middle East0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
IBBQ invests in stocks. The fund's major sectors are Health Technology, with 96.63% stocks, and Commercial Services, with 1.51% of the basket. The assets are mostly located in the North America region.
IBBQ top holdings are Amgen Inc. and Vertex Pharmaceuticals Incorporated, occupying 7.69% and 7.68% of the portfolio correspondingly.
IBBQ last dividends amounted to 0.03 USD. The quarter before, the issuer paid 0.04 USD in dividends, which shows a 40.10% decrease.
IBBQ assets under management is 34.52 M USD. It's fallen 6.66% over the last month.
IBBQ fund flows account for 1.83 M USD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
Yes, IBBQ pays dividends to its holders with the dividend yield of 0.97%. The last dividend (Jun 27, 2025) amounted to 0.03 USD. The dividends are paid quarterly.
IBBQ shares are issued by Invesco Ltd. under the brand Invesco. The ETF was launched on Jun 11, 2021, and its management style is Passive.
IBBQ expense ratio is 0.19% meaning you'd have to pay 0.19% of your investment to help manage the fund.
IBBQ follows the NASDAQ / Biotechnology. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
IBBQ invests in stocks.
IBBQ price has risen by 7.47% over the last month, and its yearly performance shows a −5.68% decrease. See more dynamics on IBBQ price chart.
NAV returns, another gauge of an ETF dynamics, showed a 10.44% increase in three-month performance and has decreased by −4.74% in a year.
NAV returns, another gauge of an ETF dynamics, showed a 10.44% increase in three-month performance and has decreased by −4.74% in a year.
IBBQ trades at a premium (0.00%) meaning the ETF is trading at a higher price than the calculated NAV.